Skip to main content
SpringerLink
Log in

Population Screening and the Prevention of Osteoporosis

  • Conference paper
Book cover HRT and Osteoporosis

Abstract

The existence of the condition called osteoporosis and the realisation that both it and its attendant fractures are susceptible of prevention, leads naturally to an enquiry as to whether it is clinically possible and logistically feasible to discover that sector of our population which is at risk. The field of screening, however, is littered with the wreckage of schemes which failed due to inadequacies in the scientific design of the project or in its applied marketing to the population. As we can have no prior knowledge of the outcome of such a complex operation, it seems prudent to carry out a mathematical simulation of the screening process together with geographically limited clinical trials, on the sound principle of Clausewitz that times spent in reconnaissance is rarely wasted. This chapter will bring together the North Humberside Osteoporosis Screening Project based on the English cities of Hull and Beverley, and the mathematical modelling work of the MRC Bone Mineralisation Group based at Leeds University.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Melton LJ, Riggs BL. Further characterisation of the heterogeneity of the osteoporotic syndromes. In: Kleerekoper M, Krane SM, eds. Clinical disorders of bone mineral metabolism. New York: Liebert, 1989; 145–52.

    Google Scholar 

  2. Ettinger B, Genant HK, Cann CE. Long-term estrogen therapy prevents bone loss and fracture. Ann Intern Med 1985; 102:319–24.

    PubMed  CAS  Google Scholar 

  3. Hutchinson TA, Polansky JM, Feinstein AR. Postmenopausal oestrogens protect against fracture of hip and distal radius. Lancet 1979; ii:705–9.

    Article  Google Scholar 

  4. Melton LJ, Riggs BL. Epidemiology of age-related fractures. In: Avioli LV, ed. The osteoporotic syndrome: detection, prevention and treatment. New York: Grune and Stratton, 1983; 45–72.

    Google Scholar 

  5. Knowelden J, Buhr AJ, Dunbar O. Incidence of fractures in persons over 35 years of age: a report to the MRC Working Party on fractures in the elderly. Br J Prev Soc Med 1964; 18:130–41.

    PubMed  CAS  Google Scholar 

  6. Chen TL, Feldman D. Distinction between alpha-fetoprotein and intracellular estrogen receptors: evidence against presence of estradiol receptors in rat bone. Endocrinology 1978; 102:236–44.

    Article  PubMed  CAS  Google Scholar 

  7. Boyce WJ, Vessey MP. Rising incidence of fracture of the proximal femur. Lancet 1985; i: 150–1.

    Article  Google Scholar 

  8. Cummings SR. Osteoporotic fractures: the magnitude of the problem. In: Christiansen C, Johansen JS, Riis BJ, eds. Copenhagen: Osteoporosis, vol. 2. Osteopress, 1987; 1193–6.

    Google Scholar 

  9. Nickens HW. A revies of factors affecting the occurrence and outcome of hip fracture, with special reference to psychosocial issues. J Am Geriatr Soc 1983; 31:166–70.

    PubMed  CAS  Google Scholar 

  10. Cummings SR, Nevitt MC. Epidemiology of hip fractures. In: Kleerekoper M, Krane SM, eds. Clinical disorders of bone and mineral metabolism. New York: Liebert, 1989; 231–6.

    Google Scholar 

  11. Melton KLJ, O’Fallon WM, Riggs BL. Secular trends in the incidence of hip fractures. Calcif Tissue Int 1987; 41:57.

    Article  PubMed  Google Scholar 

  12. Meunier P, Courpron P, Edouard C, Bernard J, Bringuier J, Vignon G. Physiological senile involution and pathological rarefaction of bone. Quantitative and comparative histological data. Clin Endocrinol Metab 1973; 2:239–56.

    Article  PubMed  CAS  Google Scholar 

  13. Mazess RB. On aging bone loss. Clin Orthop 1982; 165:239–52.

    PubMed  Google Scholar 

  14. Mazess RB, Peppier WW, Chesney RW, Lange TA, Lindgren U, Smith E Jr. Does bone measurement on the radius indicate skeletal status? J Nucl Med 1984; 25:281–8.

    PubMed  CAS  Google Scholar 

  15. Gotfredsen A, Borg J, Nilas L, Tiellesen L, Christiansen C. Representativity of regional to total bone mineral in healthy subjects and anticonvulsive treated epileptic patients. Measurements by single and dual photon absorptiometry. Eur J Clin Invest 1986; 16:198–203.

    Article  PubMed  CAS  Google Scholar 

  16. Laval-Jeantet A-M, Roger B, de Vernejoul MC, Laval-Jeantet J. Testing of dual-energy postprocessing method of QCT densitometry. J Comput Assist Tomogr 1985; 9:616–17.

    Article  Google Scholar 

  17. O’Duffy JD, Wahner HW, O’Fallon WM, Johnson KA, Muhs J, Riggs BL. Mechanism of acute lower extremity pain syndrome in fluoride-treated osteoporotic patients. Am J Med 1986; 80:561–6.

    Article  PubMed  Google Scholar 

  18. LeBlanc AD, Evans H, Jhingran S, Johnson P. High resolution bone mineral densitometry with a gamma camera. Phys Med Biol 1984; 29:25–30.

    Article  PubMed  CAS  Google Scholar 

  19. Mazess RB. Advances in single-and dual-photon absorptiometry. In: Christiansen C, Arnaud CD, Nordin BEC, Parfitt AM, Peck WA, Riggs BL, eds. Osteoporosis, Proceedings of the Copenhagen International Symposium on Osteoporosis. Glostrup, Denmark: 1984.

    Google Scholar 

  20. Wasnsich RD, Ross PD, Vogel JM. Evaluation of a screening test for fracture risk prediction: a prospective study of bone mineral content and fracture incidence. West Regional SNM, 1985.

    Google Scholar 

  21. McBroom RJ, Hayes WD, Edwards WT, Goldberg RP, White AA. Prediction of vertebral body compressive fracture using quantitative computed tomography. J Bone Joint Surg 1985; 67:1206–14.

    PubMed  CAS  Google Scholar 

  22. Kalender WA, Klotz E, Suess C. Vertebral bone mineral analysis: an integrated approach with CT. Radiology 1987; 164:419–23.

    PubMed  CAS  Google Scholar 

  23. Christiansen C, Riis BJ, Rodbro P. Prediction of rapid bone loss in postmenopausal women. Lancet 1987; i:1105–8.

    Article  Google Scholar 

  24. Eriksen EF, Berg NH, Graham ML et al. Multiple sex steroid receptors in cultured human osteoblast-like cells. International Symposium on Osteoporosis, Aalborg, 1987. Abstract 67.

    Google Scholar 

  25. Stevenson JC. Vitamin D in postmenopausal women. In: Duusma SA, Sluys Veer JVD, eds. Vitamine D 43055. Utrecht: Wetenschappelijke uitgeverij Bunge, 1983.

    Google Scholar 

  26. Morimoto S, Tsuji M, Okada T, Kumahara Y. The effects of oestrogens on human calcitonin secretion after calcium infusion in elderly female subjects. Clin Endocrinol 1980; 13:135–43.

    Article  CAS  Google Scholar 

  27. Lindsay R, Hart DM, Forrest C, Baird C. Prevention of spinal osteoporosis in oophorectomized women. Lancet 1980; ii: 1151–4.

    Article  Google Scholar 

  28. Lindsay R, Aitken JM, Anderson JB, Hart DM, MacDonald EB, Clark AC. Long-term prevention of postmenopausal osteoporosis by oestrogen. Lancet 1976; i:1038–41.

    Article  Google Scholar 

  29. Lindsay R, Hart DM, Purdie D, Ferguson MM, Clark AS, Kraszewski A. Comparative effects of oestrogen and a progestogen on bone loss in postmenopausal women. Clin Sci Mol Med 1978; 54:193–5.

    PubMed  CAS  Google Scholar 

  30. Christiansen C, Riis BT, Nilas L, Rodbro P, Deftos L. Uncoupling of bone formation and resorption by combined oestrogen and progestagen therapy in postmenopausal osteoporosis. Lancet 1985; ii:800-l.

    Article  Google Scholar 

  31. Reginster JY, Denis D, Albert A et al. 1-year controlled randomised trial of prevention of early postmenopausal bone loss by intranasal calcitonin. Lancet 1987; ii:1481–3.

    Article  Google Scholar 

  32. Overgaard K, Riis BJ, Christiansen C, Hansen MA. Effect of calcatonin given intranasally on early postmenopausal bone loss. Br Med J 1989; 299:477–9.

    Article  CAS  Google Scholar 

  33. Reginster JY, Lecart MP, Deroisy R et al. Prevention of postmenopausal bone loss by tiludronate. Lancet 1989; ii:1469–71.

    Article  Google Scholar 

  34. Horsman A, Marshall DH, Peacock M. A stochastic model of age-related bone loss and fractures. Clin Orthop 1985; 195:207–15.

    PubMed  Google Scholar 

  35. Horsman A, Burkinshaw L. Stochastic models of bone loss and fracture risk. In: Ring EFJ, Evans WD, Dixon AS eds. Osteoporosis and bone mineral measurement. York: IOPSM, 1989; 15–30.

    Google Scholar 

  36. Horsman A, Birchall MN. Assessment and modification of hip fracture risk — predictions of a stochastic model. In: Proceedings of Steenbock Symposium on Osteoporosis, Madison (in press).

    Google Scholar 

  37. Mazess RB, Barden H, Ettinger M, Shultz E. Bone density of the radius, spine, and proximal femur in osteoporosis. J Bone Miner Res 1988; 3:13–18.

    Article  PubMed  CAS  Google Scholar 

  38. Aitken M. Osteoporosis in clinical practice. Bristol: Wright, 1984.

    Google Scholar 

  39. Burns R. To a Mouse. In: Poems, chiefly in the Scottish dialect. Kilmarnock: J Wilson, 1786, 22–3.

    Google Scholar 

Download references

Authors
  1. D. W. Purdie
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. Horsman
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Clarendon Wing, Leeds General Infirmary, Leeds, LS1 3EX, UK

    James O. Drife MD, FRCS Ed, FRCOG (Professor of Obstetrics and Gynaecology) (Professor of Obstetrics and Gynaecology)

  2. King’s College Hospital, London, SE5 9RS, UK

    John W. W. Studd MD, BS, FRCOG (Consultant Obstetrician and Gynaecologist, Director) (Consultant Obstetrician and Gynaecologist, Director)

  3. The Menopause Clinic, Dulwich Hospital, East Dulwich Grove, London, SE22 8PT, UK

    John W. W. Studd MD, BS, FRCOG (Consultant Obstetrician and Gynaecologist, Director) (Consultant Obstetrician and Gynaecologist, Director)

Rights and permissions

Reprints and permissions

Copyright information

© 1990 Springer-Verlag London Limited

About this paper

Cite this paper

Purdie, D.W., Horsman, A. (1990). Population Screening and the Prevention of Osteoporosis. In: Drife, J.O., Studd, J.W.W. (eds) HRT and Osteoporosis. Springer, London. https://doi.org/10.1007/978-1-4471-1799-5_19

Download citation

  • DOI: https://doi.org/10.1007/978-1-4471-1799-5_19

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-4471-1801-5

  • Online ISBN: 978-1-4471-1799-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation